Open AccessABO-incompatible kidney transplantation using both A2 and non-A2 living donors
Author(s) -
James M. Gloor,
Donna J. Lager,
S. Breanndan Moore,
Alvaro A. Pineda,
Mary E. Fidler,
Timothy S. Larson,
Joseph P. Grande,
Thomas R. Schwab,
Matthew Griffin,
Mikel Prieto,
Scott L. Nyberg,
Jorge A. Velosa,
S. C. Textor,
Jeffrey L. Platt,
Mark D. Stegall
Publication year - 2003
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000058226.39732.32
Subject(s) - thymoglobulin , medicine , plasmapheresis , immunosuppression , abo blood group system , kidney transplantation , transplantation , daclizumab , prednisone , tacrolimus , kidney , surgery , urology , gastroenterology , immunology , antibody
Given the scarcity of cadaveric organs, efforts are intensifying to increase the availability of living donors. The current study assessed the feasibility of using ABO-incompatible living-donor kidneys to expand the donor pool.